INZY
Price
$4.06
Change
-$0.36 (-8.14%)
Updated
Nov 5, 04:00 PM (EDT)
Earnings call today
PRAX
Price
$69.93
Change
-$0.09 (-0.13%)
Updated
Nov 5, 11:55 AM (EDT)
One day until earnings call
Ad is loading...

INZY vs PRAX

Header iconINZY vs PRAX Comparison
Open Charts INZY vs PRAXBanner chart's image
Inozyme Pharma
Price$4.06
Change-$0.36 (-8.14%)
Volume$94.3K
CapitalizationN/A
Praxis Precision Medicines
Price$69.93
Change-$0.09 (-0.13%)
Volume$100
CapitalizationN/A
View a ticker or compare two or three
INZY vs PRAX Comparison Chart
Loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
INZY vs. PRAX commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INZY is a Hold and PRAX is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (INZY: $4.42 vs. PRAX: $69.99)
Brand notoriety: INZY and PRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INZY: 107% vs. PRAX: 70%
Market capitalization -- INZY: $296.58M vs. PRAX: $1.24B
INZY [@Biotechnology] is valued at $296.58M. PRAX’s [@Biotechnology] market capitalization is $1.24B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INZY’s FA Score shows that 0 FA rating(s) are green whilePRAX’s FA Score has 0 green FA rating(s).

  • INZY’s FA Score: 0 green, 5 red.
  • PRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, INZY is a better buy in the long-term than PRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INZY’s TA Score shows that 5 TA indicator(s) are bullish while PRAX’s TA Score has 4 bullish TA indicator(s).

  • INZY’s TA Score: 5 bullish, 6 bearish.
  • PRAX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, PRAX is a better buy in the short-term than INZY.

Price Growth

INZY (@Biotechnology) experienced а -7.53% price change this week, while PRAX (@Biotechnology) price change was -2.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.90%.

Reported Earning Dates

INZY is expected to report earnings on Mar 20, 2025.

PRAX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRAX($1.24B) has a higher market cap than INZY($297M). PRAX YTD gains are higher at: 214.138 vs. INZY (3.756). INZY has higher annual earnings (EBITDA): -82.82M vs. PRAX (-132.26M). PRAX has more cash in the bank: 352M vs. INZY (145M). PRAX has less debt than INZY: PRAX (1.95M) vs INZY (46.7M). PRAX has higher revenues than INZY: PRAX (1.77M) vs INZY (0).
INZYPRAXINZY / PRAX
Capitalization297M1.24B24%
EBITDA-82.82M-132.26M63%
Gain YTD3.756214.1382%
P/E RatioN/AN/A-
Revenue01.77M-
Total Cash145M352M41%
Total Debt46.7M1.95M2,400%
TECHNICAL ANALYSIS
Technical Analysis
INZYPRAX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTDCX33.630.10
+0.30%
Invesco EQV Emerging Markets All Cap C
ASCRX15.110.03
+0.20%
American Century Small Company R
UGMVX11.23N/A
N/A
Victory Global Managed Volatility
SVFCX79.00N/A
N/A
Smead Value C
IESGX21.98-0.04
-0.18%
Sit ESG Growth I

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+1.38%
BEAM - INZY
59%
Loosely correlated
+6.24%
NTLA - INZY
52%
Loosely correlated
+2.30%
DNLI - INZY
51%
Loosely correlated
+0.59%
PLRX - INZY
50%
Loosely correlated
-0.14%
PGEN - INZY
50%
Loosely correlated
-0.49%
More

PRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRAX has been loosely correlated with INZY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if PRAX jumps, then INZY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRAX
1D Price
Change %
PRAX100%
+2.43%
INZY - PRAX
38%
Loosely correlated
+1.38%
VERU - PRAX
35%
Loosely correlated
-4.39%
ZYME - PRAX
34%
Loosely correlated
+11.14%
STRO - PRAX
33%
Poorly correlated
+3.94%
CLRB - PRAX
32%
Poorly correlated
N/A
More